SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug DiscoveryCRO

PUBLISHER: Visiongain | PRODUCT CODE: 2151282

Cover Image

PUBLISHER: Visiongain | PRODUCT CODE: 2151282

Global Biopharmaceuticals Contract Manufacturing Market Report 2026-2036

PUBLISHED:
PAGES: 425 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5872.50
PDF (Team License - Up to 6 Users)
USD 6952.50
PDF (Site License)
USD 8167.50
PDF (Enterprise License - Includes Free Datasets)
USD 10320.75

Add to Cart

Description

Table of Contents

List of Tables

This report provides a comprehensive analysis of the market including market size, growth drivers, competitive positioning, and revenue forecasts across source, service, product, company size, scale of operations, and therapeutic area segments.

Cost and Time Saving Benefits Offered by Contract Services

The cost and operational efficiencies associated with outsourcing continue to drive growth in the biopharmaceutical contract manufacturing market. By partnering with CDMOs, biopharmaceutical companies can avoid substantial investments in facility construction, specialised equipment, and manufacturing personnel, while gaining access to established infrastructure and technical expertise. This approach is particularly beneficial for emerging biotechnology companies seeking to advance products through clinical development and for established pharmaceutical companies aiming to focus internal resources on innovation and portfolio expansion.

Shared infrastructure further enhances these advantages. CDMOs operate flexible manufacturing facilities equipped with modular production technologies, single-use systems, and dedicated fill-finish capabilities, enabling multiple projects to be executed simultaneously while improving facility utilisation and reducing operational overheads. Such capabilities allow sponsors to access scalable manufacturing services without committing significant capital to dedicated production assets.

In addition to lowering costs, outsourcing can accelerate manufacturing timelines through established platform processes, integrated quality systems, and end-to-end service offerings. These capabilities facilitate technology transfer, simplify scale-up activities, and support a more efficient transition from clinical development to commercial production. In February 2025, Recipharm introduced a modular Grade A isolator line designed to support faster clinical batch production with minimal revalidation requirements, highlighting the growing emphasis on manufacturing agility and streamlined operations.

Report Scope and Data Coverage

  • Global biopharmaceuticals contract manufacturing market analysis
  • Revenue forecasts to 2036 with annual growth estimates
  • Segment-level modelling across source, service, product, company size, scale of operations, and therapeutic area
  • Regional and national market forecasts across five regions and 22 leading national markets
  • Competitive intelligence on 22 leading companies

Includes both quantitative forecasting and qualitative strategic analysis covering technology, competition, trade dynamics, and supply chain developments.

Our 425-page report provides 151 tables and 204 charts/graphs.

Segmentation Framework

By Source

  • Mammalian
  • Non-mammalian

By Service

  • Process Development
  • Downstream
  • Upstream
  • Fill & Finish Operations
  • Analytical & QC Studies
  • Packaging

By Product

  • Biologics
  • Monoclonal Antibodies (mAbs)
  • Recombinant Proteins
  • Vaccines
  • Others
  • Biosimilars

By Company Size

  • Small
  • Mid-sized
  • Large

By Scale of Operations

  • Preclinical
  • Clinical
  • Commercial

By Therapeutic Area

  • Oncology
  • Autoimmune Diseases
  • Cardiovascular Diseases
  • Metabolic Diseases
  • Infectious Diseases
  • Neurology
  • Others

Geographic Coverage

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Switzerland
  • Rest of Europe

Asia Pacific

  • Japan
  • China
  • India
  • Australia
  • South Korea
  • South-East Asia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of Latin America

Middle East and Africa

  • GCC
  • South Africa
  • Rest of MEA

Company Intelligence Coverage

This report includes detailed profiles of 22 leading companies, including:

  • AbbVie Inc.
  • AGC Biologics
  • Avantor, Inc.
  • Boehringer Ingelheim GmbH
  • Bynex Co., Ltd.
  • Cambrex Corporation
  • Catalent, Inc. (A Novo Holdings Company)
  • Curia Global, Inc.
  • Cytiva
  • FUJIFILM Diosynth Biotechnologies
  • JRS Pharma
  • Jubilant Pharma Limited
  • KBI Biopharma
  • Lonza
  • Pfizer CentreOne
  • ProBioGen AG
  • Rentschler Biopharma SE
  • Samsung Biologics
  • Sandoz Group AG
  • Thermo Fisher Scientific Inc.
  • TOYOBO CO., LTD.
  • WuXi Biologics

Each profile includes:

  • Business overview
  • Financial and market positioning
  • Technology roadmap and programme wins
  • Strategic outlook

Key Questions Answered

  • How is the biopharmaceuticals contract manufacturing market evolving?
  • What is driving and restraining the biopharmaceuticals contract manufacturing market?
  • How will each biopharmaceuticals contract manufacturing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2036?
  • How will the market shares for each biopharmaceuticals contract manufacturing submarket develop from 2026 to 2036?
  • Will leading biopharmaceuticals contract manufacturing markets broadly follow macroeconomic dynamics, or will individual national markets outperform others?
  • Who are the leading players and what are their prospects over the forecast period?
  • How will the industry evolve during the period between 2026 and 2036?
  • What are the best investment options for new product and service lines?

Bespoke Intelligence and Customisation

Visiongain also provides tailored intelligence and advisory support aligned to specific client requirements. This includes:

  • Custom market segmentation and forecasts
  • Competitive benchmarking and strategy analysis
  • Supply chain and sourcing intelligence
  • Biologics manufacturing capability and capacity assessment
  • Scenario modelling including tariff and geopolitical risk

Why This Market Intelligence Matters

The biopharmaceuticals contract manufacturing market is entering a period of sustained structural growth as biologics pipelines expand, commercial manufacturing programmes accumulate, and pharmaceutical and biotechnology companies increasingly rely on specialist CDMOs for integrated end-to-end services spanning process development, drug substance manufacturing, formulation, and fill-finish. CDMOs that combine technical breadth across multiple biologic modalities, flexible multi-product capacity, advanced digital manufacturing capabilities, and strong regulatory track records are best positioned to capture long-term programme value over the next decade.

Show more
Product Code: PHA1401

Table of Contents

1 Report Overview

  • 1.1 Objectives of the Study
  • 1.2 Introduction to Biopharmaceuticals Contract Manufacturing Market
  • 1.3 What This Report Delivers
  • 1.4 Why You Should Read This Report
  • 1.5 Key Questions Answered by This Analytical Report Include:
  • 1.6 Who is This Report For?
  • 1.7 Methodology
    • 1.7.1 Market Definitions
    • 1.7.2 Market Evaluation & Forecasting Methodology
    • 1.7.3 Data Validation
      • 1.7.3.1 Primary Research
      • 1.7.3.2 Secondary Research
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Associated Visiongain Reports
  • 1.10 About Visiongain

2 Executive Summary

3 Market Overview

  • 3.1 Key Findings
  • 3.2 Market Dynamics
  • 3.3 Impact Analysis
    • 3.3.1 Market Driving Factors
      • 3.3.1.1 Rise in Investment by CMOs for Capacity Expansion
      • 3.3.1.2 Cost and Time Saving Benefits Offered by Contract Services
      • 3.3.1.3 Outsourcing as a Driver for Market Growth
      • 3.3.1.4 Growing Investments in Orphan Drugs
      • 3.3.1.5 Advancements in Manufacturing Technologies
      • 3.3.1.6 Rising demand for Biologics and Biosimilars
    • 3.3.2 Market Restraining Factors
      • 3.3.2.1 Pricing Pressure to Impede Market Growth
      • 3.3.2.2 Regulatory Scenarios
      • 3.3.2.3 Overcapacity Projected to Challenge Market Growth
      • 3.3.2.4 Global shortage of skilled bioprocess engineers
    • 3.3.3 Market Opportunities
      • 3.3.3.1 Expansion of Fill and Finish CMOs
      • 3.3.3.2 Emergence of Single-Use Bioprocessing Equipment & Solutions
      • 3.3.3.3 Emerging Economies to Offer Lucrative Growth Opportunities
      • 3.3.3.4 AI-driven predictive bioprocess control boosting yield
  • 3.1 U.S. Tariffs: What's the Impact on Biopharmaceuticals Contract Manufacturing Market?
    • 3.1.1 Overview
    • 3.1.2 V-Shaped Recovery Scenario
    • 3.1.3 Why V-Shaped Recovery?
      • 3.1.3.1 Impact from Tariffs
      • 3.1.3.2 Market Dynamics and Demand Recovery
      • 3.1.3.3 Policy and Funding Support
      • 3.1.3.4 Timeframe for Recovery
    • 3.1.4 U-Shaped Recovery Scenario
      • 3.1.4.1 Why U-Shaped Recovery?
      • 3.1.4.2 Impact from Tariffs
      • 3.1.4.3 Market Dynamics and Demand Recovery
      • 3.1.4.4 Policy and Funding Support
      • 3.1.4.5 Timeframe for Recovery
    • 3.1.5 L Shaped Recovery Scenario
      • 3.1.5.1 Why L-Shaped Recovery?
      • 3.1.5.2 Impact from Tariffs
      • 3.1.5.3 Market Dynamics and Demand Recovery
      • 3.1.5.4 Policy and Funding Support
      • 3.1.5.5 Timeframe for Recovery
    • 3.1.6 What Strategic Considerations Should Clients Factor into Their Near-term (2026-2031) and Long-term (2026-2036) Planning?
    • 3.1.7 Impact of U.S. and China Trade War on Biopharmaceuticals Contract Manufacturing Market
    • 3.1.8 How Might the Most Impacted Countries Experience Positive and Negative Effects Resulting from These Policy Changes?
  • 3.2 SWOT Analysis
    • 3.2.1 Strengths
    • 3.2.2 Weaknesses
    • 3.2.3 Opportunities
    • 3.2.4 Threats
  • 3.3 Porter's Five Forces Analysis
    • 3.3.1 Bargaining Power of Buyers
    • 3.3.2 Bargaining Power of Suppliers
    • 3.3.3 Competitive Rivalry
    • 3.3.4 Threat of Substitutes
    • 3.3.5 Threat of New Entrants
  • 3.4 PEST Analysis
    • 3.4.1 Political Factors Impacting Biopharmaceuticals Contract Manufacturing Market
    • 3.4.2 Economic Factors Impacting Biopharmaceuticals Contract Manufacturing Market
    • 3.4.3 Social Factors Impacting Biopharmaceuticals Contract Manufacturing Market
    • 3.4.4 Technological Factors Impacting Biopharmaceuticals Contract Manufacturing Market

4 Biopharmaceuticals Contract Manufacturing Market Analysis by Source

  • 4.1 Key Findings
  • 4.2 Source Segment: Market Attractiveness Index
  • 4.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Source
  • 4.4 Mammalian
    • 4.4.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
    • 4.4.2 Market Share by Region, 2026 & 2036 (%)
  • 4.5 Non-mammalian
    • 4.5.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
    • 4.5.2 Market Share by Region, 2026 & 2036 (%)

5 Biopharmaceuticals Contract Manufacturing Market Analysis by Service

  • 5.1 Key Findings
  • 5.2 Service Segment: Market Attractiveness Index
  • 5.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Service
  • 5.4 Process Development
    • 5.4.1 Upstream Process Development
    • 5.4.2 Downstream Process Development
    • 5.4.3 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
    • 5.4.4 Market Share by Region, 2026 & 2036 (%)
  • 5.5 Fill & Finish Operations
    • 5.5.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
    • 5.5.2 Market Share by Region, 2026 & 2036 (%)
  • 5.6 Analytical & QC Studies
    • 5.6.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
    • 5.6.2 Market Share by Region, 2026 & 2036 (%)
  • 5.7 Packaging
    • 5.7.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
    • 5.7.2 Market Share by Region, 2026 & 2036 (%)

6 Biopharmaceuticals Contract Manufacturing Market Analysis by Product

  • 6.1 Key Findings
  • 6.2 Product Segment: Market Attractiveness Index
  • 6.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Product
  • 6.4 Biologics
    • 6.4.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
    • 6.4.2 Market Share by Region, 2026 & 2036 (%)
  • 6.5 Biosimilars
    • 6.5.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
    • 6.5.2 Market Share by Region, 2026 & 2036 (%)

7 Biopharmaceuticals Contract Manufacturing Market Analysis by Company Size

  • 7.1 Key Findings
  • 7.2 Company Size Segment: Market Attractiveness Index
  • 7.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Company Size
  • 7.4 Small
    • 7.4.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
    • 7.4.2 Market Share by Region, 2026 & 2036 (%)
  • 7.5 Mid-sized
    • 7.5.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
    • 7.5.2 Market Share by Region, 2026 & 2036 (%)
  • 7.6 Large
    • 7.6.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
    • 7.6.2 Market Share by Region, 2026 & 2036 (%)

8 Biopharmaceuticals Contract Manufacturing Market Analysis by Scale of Operations

  • 8.1 Key Findings
  • 8.2 Scale of Operations Segment: Market Attractiveness Index
  • 8.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Scale of Operations
  • 8.4 Preclinical
    • 8.4.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
    • 8.4.2 Market Share by Region, 2026 & 2036 (%)
  • 8.5 Clinical
    • 8.5.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
    • 8.5.2 Market Share by Region, 2026 & 2036 (%)
  • 8.6 Commercial
    • 8.6.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
    • 8.6.2 Market Share by Region, 2026 & 2036 (%)

9 Biopharmaceuticals Contract Manufacturing Market Analysis by Therapeutic Area

  • 9.1 Key Findings
  • 9.2 Therapeutic Area Segment: Market Attractiveness Index
  • 9.3 Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Therapeutic Area
  • 9.4 Oncology
    • 9.4.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
    • 9.4.2 Market Share by Region, 2026 & 2036 (%)
  • 9.5 Autoimmune Diseases
    • 9.5.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
    • 9.5.2 Market Share by Region, 2026 & 2036 (%)
  • 9.6 Cardiovascular Diseases
    • 9.6.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
    • 9.6.2 Market Share by Region, 2026 & 2036 (%)
  • 9.7 Metabolic Diseases
    • 9.7.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
    • 9.7.2 Market Share by Region, 2026 & 2036 (%)
  • 9.8 Infectious Diseases
    • 9.8.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
    • 9.8.2 Market Share by Region, 2026 & 2036 (%)
  • 9.9 Neurology
    • 9.9.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
    • 9.9.2 Market Share by Region, 2026 & 2036 (%)
  • 9.10 Others
    • 9.10.1 Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
    • 9.10.2 Market Share by Region, 2026 & 2036 (%)

10 Biopharmaceuticals Contract Manufacturing Market Analysis by Region

  • 10.1 Key Findings
  • 10.2 Regional Market Size Estimation and Forecast

11 North America Biopharmaceuticals Contract Manufacturing Market Analysis

  • 11.1 Key Findings
  • 11.2 North America Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
  • 11.3 North America Biopharmaceuticals Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Million)
  • 11.4 North America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Country
  • 11.5 North America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Source
  • 11.6 North America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Service
  • 11.7 North America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Product
  • 11.8 North America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Company Size
  • 11.9 North America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Scale of Operations
  • 11.10 North America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Therapeutic Area
  • 11.11 U.S. Biopharmaceuticals Contract Manufacturing Market Analysis
  • 11.12 Canada Biopharmaceuticals Contract Manufacturing Market Analysis

12 Europe Biopharmaceuticals Contract Manufacturing Market Analysis

  • 12.1 Key Findings
  • 12.2 Europe Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
  • 12.3 Europe Biopharmaceuticals Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Million)
  • 12.4 Europe Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Country
  • 12.5 Europe Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Source
  • 12.6 Europe Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Service
  • 12.7 Europe Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Product
  • 12.8 Europe Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Company Size
  • 12.9 Europe Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Scale of Operations
  • 12.10 Europe Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Therapeutic Area
  • 12.11 Germany Biopharmaceuticals Contract Manufacturing Market Analysis
  • 12.12 UK Biopharmaceuticals Contract Manufacturing Market Analysis
  • 12.13 France Biopharmaceuticals Contract Manufacturing Market Analysis
  • 12.14 Italy Biopharmaceuticals Contract Manufacturing Market Analysis
  • 12.15 Spain Biopharmaceuticals Contract Manufacturing Market Analysis
  • 12.16 Russia Biopharmaceuticals Contract Manufacturing Market Analysis
  • 12.17 Netherlands Biopharmaceuticals Contract Manufacturing Market Analysis
  • 12.18 Switzerland Biopharmaceuticals Contract Manufacturing Market Analysis
  • 12.19 Rest of Europe Biopharmaceuticals Contract Manufacturing Market Analysis

13 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Analysis

  • 13.1 Key Findings
  • 13.2 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
  • 13.3 Asia Pacific Biopharmaceuticals Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Million)
  • 13.4 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Country
  • 13.5 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Source
  • 13.6 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Service
  • 13.7 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Product
  • 13.8 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Company Size
  • 13.9 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Scale of Operations
  • 13.10 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Therapeutic Area
  • 13.11 Japan Biopharmaceuticals Contract Manufacturing Market Analysis
  • 13.12 China Biopharmaceuticals Contract Manufacturing Market Analysis
  • 13.13 India Biopharmaceuticals Contract Manufacturing Market Analysis
  • 13.14 Australia Biopharmaceuticals Contract Manufacturing Market Analysis
  • 13.15 South Korea Biopharmaceuticals Contract Manufacturing Market Analysis
  • 13.16 South-East Asia Biopharmaceuticals Contract Manufacturing Market Analysis
  • 13.17 Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing Market Analysis

14 Latin America Biopharmaceuticals Contract Manufacturing Market Analysis

  • 14.1 Key Findings
  • 14.2 Latin America Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
  • 14.3 Latin America Biopharmaceuticals Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Million)
  • 14.4 Latin America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Country
  • 14.5 Latin America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Source
  • 14.6 Latin America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Service
  • 14.7 Latin America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Product
  • 14.8 Latin America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Company Size
  • 14.9 Latin America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Scale of Operations
  • 14.10 Latin America Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Therapeutic Area
  • 14.11 Brazil Biopharmaceuticals Contract Manufacturing Market Analysis
  • 14.12 Mexico Biopharmaceuticals Contract Manufacturing Market Analysis
  • 14.13 Argentina Biopharmaceuticals Contract Manufacturing Market Analysis
  • 14.14 Colombia Biopharmaceuticals Contract Manufacturing Market Analysis
  • 14.15 Rest of Latin America Biopharmaceuticals Contract Manufacturing Market Analysis

15 MEA Biopharmaceuticals Contract Manufacturing Market Analysis

  • 15.1 Key Findings
  • 15.2 MEA Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
  • 15.3 MEA Biopharmaceuticals Contract Manufacturing Market by Country, 2026, 2031 & 2036 (US$ Million)
  • 15.4 MEA Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Country
  • 15.5 MEA Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Source
  • 15.6 MEA Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Service
  • 15.7 MEA Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Product
  • 15.8 MEA Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Company Size
  • 15.9 MEA Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Scale of Operations
  • 15.10 MEA Biopharmaceuticals Contract Manufacturing Market Size Estimation and Forecast by Therapeutic Area
  • 15.11 GCC Biopharmaceuticals Contract Manufacturing Market Analysis
  • 15.12 South Africa Biopharmaceuticals Contract Manufacturing Market Analysis
  • 15.13 Rest of MEA Biopharmaceuticals Contract Manufacturing Market Analysis

16 Company Profiles

  • 16.1 AbbVie, Inc.
    • 16.1.1 Company Snapshot
    • 16.1.2 Company Overview
    • 16.1.3 Financial Analysis
      • 16.1.3.1 Net Revenue, 2022-2025
      • 16.1.3.2 R&D Expenses, 2022-2025
      • 16.1.3.3 Regional Market Shares, 2025
      • 16.1.3.4 Business Segment Market Shares, 2025
    • 16.1.4 Service Benchmarking
  • 16.2 AGC Biologics
    • 16.2.1 Company Snapshot
    • 16.2.2 Company Overview
    • 16.2.3 Service Benchmarking
    • 16.2.4 Strategic Outlook
  • 16.3 Avantor, Inc.
    • 16.3.1 Company Snapshot
    • 16.3.2 Company Overview
    • 16.3.3 Financial Analysis
      • 16.3.3.1 Net Revenue, 2022-2025
      • 16.3.3.2 Regional Market Shares, 2025
      • 16.3.3.3 Business Segment Market Shares, 2025
    • 16.3.4 Service Benchmarking
    • 16.3.5 Strategic Outlook
  • 16.4 Binex Co., Ltd.
    • 16.4.1 Company Snapshot
    • 16.4.2 Company Overview
    • 16.4.3 Service Benchmarking
  • 16.5 Boehringer Ingelheim GmbH
    • 16.5.1 Company Snapshot
    • 16.5.2 Company Overview
    • 16.5.3 Financial Analysis
      • 16.5.3.1 Net Revenue, 2022-2025
      • 16.5.3.2 R&D Expenses, 2022-2025
      • 16.5.3.3 Regional Market Shares, 2025
      • 16.5.3.4 Business Segment Market Shares, 2025
    • 16.5.4 Service Benchmarking
  • 16.6 FUJIFILM Diosynth Biotechnologies
    • 16.6.1 Company Snapshot
    • 16.6.2 Company Overview
    • 16.6.3 Service Benchmarking
    • 16.6.4 Strategic Outlook
  • 16.7 Lonza
    • 16.7.1 Company Snapshot
    • 16.7.2 Company Overview
    • 16.7.3 Financial Analysis
      • 16.7.3.1 Net Revenue, 2022-2025
      • 16.7.3.2 R&D Expenses, 2022-2025
      • 16.7.3.3 Regional Market Shares, 2025
      • 16.7.3.4 Business Segment Market Shares, 2025
    • 16.7.4 Service Benchmarking
    • 16.7.5 Strategic Outlook
  • 16.8 ProBioGen
    • 16.8.1 Company Snapshot
    • 16.8.2 Company Overview
    • 16.8.3 Service Benchmarking
    • 16.8.4 Strategic Outlook
  • 16.9 Rentschler Biopharma SE
    • 16.9.1 Company Snapshot
    • 16.9.2 Company Overview
    • 16.9.3 Service Benchmarking
    • 16.9.4 Strategic Outlook
  • 16.10 Samsung Biologics
    • 16.10.1 Company Snapshot
    • 16.10.2 Company Overview
    • 16.10.3 Service Benchmarking
    • 16.10.4 Strategic Outlook
  • 16.11 Sandoz
    • 16.11.1 Company Snapshot
    • 16.11.2 Company Overview
    • 16.11.3 Financial Analysis
      • 16.11.3.1 Net Revenue, 2022-2025
      • 16.11.3.2 R&D Expenses, 2022-2025
      • 16.11.3.3 Regional Market Shares, 2025
      • 16.11.3.4 Business Segment Market Shares, 2025
    • 16.11.4 Service Benchmarking
    • 16.11.5 Strategic Outlook
  • 16.12 TOYOBO CO., LTD.
    • 16.12.1 Company Snapshot
    • 16.12.2 Company Overview
    • 16.12.3 Service Benchmarking
  • 16.13 WuXi Biologics
    • 16.13.1 Company Snapshot
    • 16.13.2 Company Overview
    • 16.13.3 Financial Analysis
      • 16.13.3.1 Net Revenue, 2022-2025
      • 16.13.3.2 Regional Market Shares, 2025
      • 16.13.3.3 Business Segment Market Shares, 2025
    • 16.13.4 Service Benchmarking
    • 16.13.5 Strategic Outlook
  • 16.14 JRS PHARMA
    • 16.14.1 Company Snapshot
    • 16.14.2 Company Overview
    • 16.14.3 Service Benchmarking
  • 16.15 Thermo Fisher Scientific
    • 16.15.1 Company Snapshot
    • 16.15.2 Company Overview
    • 16.15.3 Financial Analysis
      • 16.15.3.1 Net Revenue, 2022-2025
      • 16.15.3.2 R&D, 2022-2025
      • 16.15.3.3 Regional Market Shares, 2025
      • 16.15.3.4 Business Segment Market Shares, 2025
    • 16.15.4 Service Benchmarking
  • 16.16 Cambrex Corporation
    • 16.16.1 Company Snapshot
    • 16.16.2 Company Overview
    • 16.16.3 Service Benchmarking
    • 16.16.4 Strategic Outlook
  • 16.17 Curia Global, Inc.
    • 16.17.1 Company Snapshot
    • 16.17.2 Company Overview
    • 16.17.3 Service Benchmarking
    • 16.17.4 Strategic Outlook
  • 16.18 Pfizer CentreOne
    • 16.18.1 Company Snapshot
    • 16.18.2 Company Overview
    • 16.18.3 Financial Analysis
      • 16.18.3.1 Net Revenue, 2022-2025
      • 16.18.3.2 R&D, 2022-2025
      • 16.18.3.3 Regional Market Shares, 2025
      • 16.18.3.4 Business Segment Market Shares, 2025
    • 16.18.4 Service Benchmarking
  • 16.19 Jubilant Pharma Limited
    • 16.19.1 Company Snapshot
    • 16.19.2 Company Overview
    • 16.19.3 Service Benchmarking
  • 16.20 Catalent, Inc. (Novo Holdings)
    • 16.20.1 Company Snapshot
    • 16.20.2 Company Overview
    • 16.20.3 Financial Analysis
      • 16.20.3.1 Net Revenue, 2022-2025
    • 16.20.4 Service Benchmarking
    • 16.20.5 Strategic Outlook
  • 16.21 KBI Biopharma
    • 16.21.1 Company Snapshot
    • 16.21.2 Company Overview
    • 16.21.3 Service Benchmarking
    • 16.21.4 Strategic Outlook
  • 16.22 Cytiva
    • 16.22.1 Company Snapshot
    • 16.22.2 Company Overview
    • 16.22.3 Service Benchmarking
    • 16.22.4 Strategic Outlook

17 Conclusion and Recommendations

  • 17.1 Concluding Remarks from Visiongain
  • 17.2 Recommendations for Market Players
Show more
Product Code: PHA1401

List of Tables

  • Table 1 Biopharmaceuticals Contract Manufacturing Market Snapshot, 2026 & 2036 (US$ million, CAGR %)
  • Table 2 Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2026-2036 (US$ Mn, AGR %, CAGR %): "V" Shaped Recovery
  • Table 3 Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2026-2036 (US$ Mn, AGR %, CAGR %): "U" Shaped Recovery
  • Table 4 Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2026-2036 (US$ Mn, AGR %, CAGR %): "L" Shaped Recovery
  • Table 5 Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 6 Mammalian Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 7 Non-mammalian Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 8 Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 9 Process Development Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 10 Fill & Finish Operations Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 11 Analytical & QC Studies Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 12 Packaging Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 13 Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 14 Biologics Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 15 Biosimilars Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 16 Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 17 Small Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 18 Mid-sized Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 19 Large Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 20 Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 21 Preclinical Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 22 Clinical Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 23 Commercial Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 24 Biopharmaceuticals Contract Manufacturing Market Forecast by Region, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 25 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 26 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 27 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 28 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 29 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 30 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 31 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 32 U.S. Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 33 Canada Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 34 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 35 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 36 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 37 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 38 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 39 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 40 Germany Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 41 UK Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 42 France Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 43 Italy Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 44 Spain Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 45 Russia Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 46 Netherlands Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 47 Switzerland Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 48 Rest of Europe Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 49 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 50 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 51 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 52 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 53 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 54 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 55 Japan Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 56 China Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 57 India Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 58 Australia Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 59 South Korea Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 60 South-East Asia Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 61 Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 62 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 63 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 64 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 65 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 66 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 67 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 68 Brazil Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 69 Mexico Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 70 Argentina Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 71 Colombia Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 72 Rest of Latin America Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 73 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 74 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 75 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 76 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 77 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 78 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operation, 2026-2036 (US$ mn, AGR%, CAGR%)
  • Table 79 GCC Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 80 South Africa Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 81 Rest of MEA Biopharmaceuticals Contract Manufacturing) Market Forecast, 2026-2036 (US$ Million, AGR %, CAGR %)
  • Table 82 AbbVie, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 83 AbbVie, Inc.: Service Benchmarking
  • Table 84 AGC Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 85 AGC Biologics: Service Benchmarking
  • Table 86 AGC Biologics: Strategic Outlook
  • Table 87 Avantor, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 88 Avantor, Inc.: Service Benchmarking
  • Table 89 Avantor, Inc.: Strategic Outlook
  • Table 90 Binex Co., Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 91 Binex Co., Ltd.: Service Benchmarking
  • Table 92 Boehringer Ingelheim GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 93 Boehringer Ingelheim GmbH: Service Benchmarking
  • Table 94 FUJIFILM Diosynth Biotechnologies: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 95 FUJIFILM Diosynth Biotechnologies: Service Benchmarking
  • Table 96 FUJIFILM Diosynth Biotechnologies: Strategic Outlook
  • Table 97 Lonza: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 98 Lonza: Service Benchmarking
  • Table 99 Lonza: Strategic Outlook
  • Table 100 ProBioGen: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 101 ProBioGen: Service Benchmarking
  • Table 102 ProBioGen: Strategic Outlook
  • Table 103 Rentschler Biopharma SE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 104 Rentschler Biopharma SE: Service Benchmarking
  • Table 105 Rentschler Biopharma SE: Strategic Outlook
  • Table 106 Samsung Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 107 Samsung Biologics: Service Benchmarking
  • Table 108 Samsung Biologics: Strategic Outlook
  • Table 109 Sandoz: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 110 Sandoz: Service Benchmarking
  • Table 111 Sandoz: Strategic Outlook
  • Table 112 TOYOBO CO., LTD.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 113 TOYOBO CO., LTD.: Service Benchmarking
  • Table 114 WuXi Biologics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 115 WuXi Biologics: Service Benchmarking
  • Table 116 WuXi Biologics: Strategic Outlook
  • Table 117 JRS PHARMA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 118 JRS PHARMA: Service Benchmarking
  • Table 119 Thermo Fisher Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 120 Thermo Fisher Scientific: Service Benchmarking
  • Table 121 Cambrex Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 122 Cambrex Corporation: Service Benchmarking
  • Table 123 Cambrex Corporation: Strategic Outlook
  • Table 124 Curia Global, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 125 Curia Global, Inc.: Service Benchmarking
  • Table 126 Curia Global, Inc.: Strategic Outlook
  • Table 127 Pfizer CentreOne: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 128 Pfizer CentreOne: Service Benchmarking
  • Table 129 Jubilant Pharma Limited: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 130 Jubilant Pharma Limited: Service Benchmarking
  • Table 131 Catalent, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 132 Catalent, Inc: Service Benchmarking
  • Table 133 Catalent, Inc: Strategic Outlook
  • Table 134 KBI Biopharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 135 KBI Biopharma: Service Benchmarking
  • Table 136 KBI Biopharma: Strategic Outlook
  • Table 137 Cytiva: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
  • Table 138 Cytiva: Service Benchmarking
  • Table 139 Cytiva: Strategic Outlook

List of Figures

  • Figure 1 Biopharmaceuticals Contract Manufacturing Market Segmentation
  • Figure 2 Biopharmaceuticals Contract Manufacturing Market by Source: Market Attractiveness Index
  • Figure 3 Biopharmaceuticals Contract Manufacturing Market by Service: Market Attractiveness Index
  • Figure 4 Biopharmaceuticals Contract Manufacturing Market by Product: Market Attractiveness Index
  • Figure 5 Biopharmaceuticals Contract Manufacturing Market by Company Size: Market Attractiveness Index
  • Figure 6 Biopharmaceuticals Contract Manufacturing Market by Scale of Operations: Market Attractiveness Index
  • Figure 7 Biopharmaceuticals Contract Manufacturing Market by Therapeutic Area: Market Attractiveness Index
  • Figure 8 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Region
  • Figure 9 Biopharmaceuticals Contract Manufacturing Market: Market Dynamics
  • Figure 10 Biopharmaceuticals Contract Manufacturing Market: Impact Analysis
  • Figure 11 Biopharmaceuticals Contract Manufacturing Market by Region, 2026-2036 (US$ Million, AGR %), Tariff Impact: V-Shaped Recovery Scenario
  • Figure 12 Biopharmaceuticals Contract Manufacturing Market by Region, 2026-2036 (US$ Million, AGR %), Tariff Impact: U-Shaped Recovery Scenario
  • Figure 13 Biopharmaceuticals Contract Manufacturing Market by Region, 2026-2036 (US$ Million, AGR %), Tariff Impact: L-Shaped Recovery Scenario
  • Figure 14 Short Term & Long Term Planning
  • Figure 15 Impact of U.S. and China Trade War
  • Figure 1 Most Impacted Countries
  • Figure 2 SWOT Analysis
  • Figure 3 Porter's Five Forces Analysis
  • Figure 4 PEST Analysis
  • Figure 5 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Source
  • Figure 6 Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ Million, AGR %)
  • Figure 7 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2026, 2031 & 2036 (%)
  • Figure 8 Mammalian Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
  • Figure 9 Mammalian Segment Market Share Forecast by Region, 2026 & 2036 (%)
  • Figure 10 Non-mammalian Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
  • Figure 11 Non-mammalian Segment Market Share Forecast by Region, 2026 & 2036 (%)
  • Figure 12 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Source
  • Figure 13 Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
  • Figure 14 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2026, 2031 & 2036 (%)
  • Figure 15 Process Development Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
  • Figure 16 Process Development Segment Market Share Forecast by Region, 2026 & 2036 (%)
  • Figure 17 Fill & Finish Operations Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
  • Figure 18 Fill & Finish Operations Segment Market Share Forecast by Region, 2026 & 2036 (%)
  • Figure 19 Analytical & QC Studies Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
  • Figure 20 Analytical & QC Studies Segment Market Share Forecast by Region, 2026 & 2036 (%)
  • Figure 21 Packaging Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
  • Figure 22 Packaging Segment Market Share Forecast by Region, 2026 & 2036 (%)
  • Figure 23 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Product
  • Figure 24 Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ Million, AGR %)
  • Figure 25 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2026, 2031 & 2036 (%)
  • Figure 26 Biologics Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
  • Figure 27 Biologics Segment Market Share Forecast by Region, 2026 & 2036 (%)
  • Figure 28 Biosimilars Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
  • Figure 29 Biosimilars Segment Market Share Forecast by Region, 2026 & 2036 (%)
  • Figure 30 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Company Size
  • Figure 31 Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ Million, AGR %)
  • Figure 32 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2026, 2031 & 2036 (%)
  • Figure 33 Small Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
  • Figure 34 Small Segment Market Share Forecast by Region, 2026 & 2036 (%)
  • Figure 35 Mid-sized Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
  • Figure 36 Mid-sized Segment Market Share Forecast by Region, 2026 & 2036 (%)
  • Figure 37 Large Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
  • Figure 38 Large Segment Market Share Forecast by Region, 2026 & 2036 (%)
  • Figure 39 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Scale of Operations
  • Figure 40 Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2026-2036 (US$ Million, AGR %)
  • Figure 41 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2026, 2031 & 2036 (%)
  • Figure 42 Preclinical Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
  • Figure 43 Preclinical Segment Market Share Forecast by Region, 2026 & 2036 (%)
  • Figure 44 Clinical Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
  • Figure 45 Clinical Segment Market Share Forecast by Region, 2026 & 2036 (%)
  • Figure 46 Commercial Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
  • Figure 47 Commercial Segment Market Share Forecast by Region, 2026 & 2036 (%)
  • Figure 48 Biopharmaceuticals Contract Manufacturing Market Attractiveness Index by Therapeutic Area
  • Figure 49 Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
  • Figure 50 Biopharmaceuticals Contract Manufacturing Market Share Forecast Therapeutic Area, 2026, 2031 & 2036 (%)
  • Figure 51 Oncology Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
  • Figure 52 Oncology Segment Market Share Forecast by Region, 2026 & 2036 (%)
  • Figure 53 Autoimmune Diseses Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
  • Figure 54 Autoimmune Diseases Segment Market Share Forecast by Region, 2026 & 2036 (%)
  • Figure 55 Cardiovascular Diseases Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
  • Figure 56 Cardiovascular Diseases Segment Market Share Forecast by Region, 2026 & 2036 (%)
  • Figure 57 Metabolic Diseases Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
  • Figure 58 Metabolic Diseases Segment Market Share Forecast by Region, 2026 & 2036 (%)
  • Figure 59 Infectious Diseases Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
  • Figure 60 Infectious Diseases Segment Market Share Forecast by Region, 2026 & 2036 (%)
  • Figure 61 Neurology Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
  • Figure 62 Neurology Segment Market Share Forecast by Region, 2026 & 2036 (%)
  • Figure 63 Others Segment Market Forecast by Region, 2026-2036 (US$ Million, AGR %)
  • Figure 64 Others Segment Market Share Forecast by Region, 2026 & 2036 (%)
  • Figure 65 Biopharmaceuticals Contract Manufacturing Market Forecast by Region 2026, 2031 & 2036 (Revenue, CAGR%)
  • Figure 66 Biopharmaceuticals Contract Manufacturing Market Share Forecast by Region 2026, 2031 & 2036 (%)
  • Figure 67 Biopharmaceuticals Contract Manufacturing Market by Region, 2026-2036 (US$ Mn)
  • Figure 68 North America Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
  • Figure 69 North America Biopharmaceuticals Contract Manufacturing Market by Region, 2026, 2031 & 2036 (US$ Million)
  • Figure 70 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %)
  • Figure 71 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2026 & 2036 (%)
  • Figure 72 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ Million, AGR %)
  • Figure 73 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2026 & 2036 (%)
  • Figure 74 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
  • Figure 75 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2026 & 2036 (%)
  • Figure 76 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ Million, AGR %)
  • Figure 77 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2026 & 2036 (%)
  • Figure 78 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ Million, AGR %)
  • Figure 79 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2026 & 2036 (%)
  • Figure 80 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2026-2036 (US$ Million, AGR %)
  • Figure 81 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2026 & 2036 (%)
  • Figure 82 North America Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
  • Figure 83 North America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Therapeutic Area, 2026 & 2036 (%)
  • Figure 84 U.S. Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
  • Figure 85 Canada Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
  • Figure 86 Europe Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
  • Figure 87 Europe Biopharmaceuticals Contract Manufacturing Market by Region, 2026, 2031 & 2036 (US$ Million)
  • Figure 88 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %)
  • Figure 89 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2026 & 2036 (%)
  • Figure 90 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ Million, AGR %)
  • Figure 91 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2026 & 2036 (%)
  • Figure 92 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
  • Figure 93 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2026 & 2036 (%)
  • Figure 94 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ Million, AGR %)
  • Figure 95 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2026 & 2036 (%)
  • Figure 96 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ Million, AGR %)
  • Figure 97 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2026 & 2036 (%)
  • Figure 98 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2026-2036 (US$ Million, AGR %)
  • Figure 99 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2026 & 2036 (%)
  • Figure 100 Europe Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
  • Figure 101 Europe Biopharmaceuticals Contract Manufacturing Market Share Forecast by Therapeutic Area, 2026 & 2036 (%)
  • Figure 102 Germany Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
  • Figure 103 UK Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
  • Figure 104 France Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
  • Figure 105 Italy Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
  • Figure 106 Spain Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
  • Figure 107 Russia Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
  • Figure 108 Netherlands Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
  • Figure 109 Switzerland Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
  • Figure 110 Rest of Europe Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
  • Figure 111 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
  • Figure 112 Asia Pacific Biopharmaceuticals Contract Manufacturing Market by Region, 2026, 2031 & 2036 (US$ Million)
  • Figure 113 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %)
  • Figure 114 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2026 & 2036 (%)
  • Figure 115 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ Million, AGR %)
  • Figure 116 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2026 & 2036 (%)
  • Figure 117 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
  • Figure 118 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2026 & 2036 (%)
  • Figure 119 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ Million, AGR %)
  • Figure 120 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2026 & 2036 (%)
  • Figure 121 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ Million, AGR %)
  • Figure 122 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2026 & 2036 (%)
  • Figure 123 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2026-2036 (US$ Million, AGR %)
  • Figure 124 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2026 & 2036 (%)
  • Figure 125 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
  • Figure 126 Asia Pacific Biopharmaceuticals Contract Manufacturing Market Share Forecast by Therapeutic Area, 2026 & 2036 (%)
  • Figure 127 Japan Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
  • Figure 128 China Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
  • Figure 129 India Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
  • Figure 130 Australia Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
  • Figure 131 South Korea Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
  • Figure 132 South-East Asia Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
  • Figure 133 Rest of Asia Pacific Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
  • Figure 134 Latin America Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
  • Figure 135 Latin America Biopharmaceuticals Contract Manufacturing Market by Region, 2026, 2031 & 2036 (US$ Million)
  • Figure 136 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %)
  • Figure 137 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2026 & 2036 (%)
  • Figure 138 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ Million, AGR %)
  • Figure 139 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2026 & 2036 (%)
  • Figure 140 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
  • Figure 141 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2026 & 2036 (%)
  • Figure 142 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ Million, AGR %)
  • Figure 143 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2026 & 2036 (%)
  • Figure 144 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ Million, AGR %)
  • Figure 145 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Company Size, 2026 & 2036 (%)
  • Figure 146 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Scale of Operations, 2026-2036 (US$ Million, AGR %)
  • Figure 147 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Scale of Operations, 2026 & 2036 (%)
  • Figure 148 Latin America Biopharmaceuticals Contract Manufacturing Market Forecast by Therapeutic Area, 2026-2036 (US$ Million, AGR %)
  • Figure 149 Latin America Biopharmaceuticals Contract Manufacturing Market Share Forecast by Therapeutic Area, 2026 & 2036 (%)
  • Figure 150 Brazil Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
  • Figure 151 Mexico Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
  • Figure 152 Argentina Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
  • Figure 153 Colombia Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
  • Figure 154 Rest of Latin America Biopharmaceuticals Contract Manufacturing Market Forecast, 2026-2036 (US$ Million, AGR %)
  • Figure 155 MEA Biopharmaceuticals Contract Manufacturing Market Attractiveness Index
  • Figure 156 MEA Biopharmaceuticals Contract Manufacturing Market by Region, 2026, 2031 & 2036 (US$ Million)
  • Figure 157 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Country, 2026-2036 (US$ Million, AGR %)
  • Figure 158 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Country, 2026 & 2036 (%)
  • Figure 159 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Source, 2026-2036 (US$ Million, AGR %)
  • Figure 160 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source, 2026 & 2036 (%)
  • Figure 161 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Service, 2026-2036 (US$ Million, AGR %)
  • Figure 162 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service, 2026 & 2036 (%)
  • Figure 163 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Product, 2026-2036 (US$ Million, AGR %)
  • Figure 164 MEA Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product, 2026 & 2036 (%)
  • Figure 165 MEA Biopharmaceuticals Contract Manufacturing Market Forecast by Company Size, 2026-2036 (US$ M
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!